# Tocilizumab

## Actemra inj 162mg/0.9mL

##### 臨採

| TAH Drug Code      | [IACTM](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IACTM){:target="_blank"}                                                                                                                                                                                                                                                                                        |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Moderate to severe active RA in adult patients, given alone or in combination w/ methotrexate (MTX) &/or other DMARDs.                                                                                                                                                                                                                                                          |
| Dosing             | SC, rheumatoid arthritis, giant cell arteritis: <100 kg 162 mg once every other week, increase to 162 mg once a week based on clinical response; > or =100 kg 162 mg once a week.                                                                                                                                                                                               |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                   |
| Contraindications  | Hypersensitivity to tocilizumab.                                                                                                                                                                                                                                                                                                                                                |
| Adverse Effects    | Upper resp tract infections, cellulitis, oral herpes simplex, herpes zoster; abdominal pain, mouth ulceration, gastritis; rash, pruritus, urticaria; headache, dizziness; increased hepatic transaminases, increased wt; HTN; leucopenia, neutropenia; hypercholesterolaemia; peripheral oedema, hypersensitivity reaction, inj site reaction; cough, dyspnoea; conjunctivitis. |
| Pregnancy          | No (Limited) Human Data – Probably Compatible                                                                                                                                                                                                                                                                                                                                   |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                   |
| More Info          | [UpToDate](https://www.uptodate.com/contents/tocilizumab-drug-information){:target="_blank"}                                                                                                                                                                                                                                                                                    |

## Actemra Infusion 80mg/4mL/Vial 專案(限Covid-19)

##### 臨採

| TAH Drug Code      | [IACTMV](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IACTMV){:target="_blank"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Rheumatoid Arthritis (RA); Polyarticular Juvenile Idiopathic Arthritis (pJIA); Systemic Juvenile Idiopathic Arthritis (sJIA).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | TFDA新型冠狀病毒（SARS-CoV-2）感染臨床處置暫行指引第十一版: 與dexamethasone合併用於嚴重肺炎以上(未使用吸氧治療下SpO2=<94%、需使用吸氧治療、高流量氧氣或非侵襲性呼吸器、使用機械式呼吸器或ECMO)之病患；或與dexamethasone + remdesivir 合併用於未使用吸氧治療下SpO2=<94%、需使用吸氧治療、高流量氧氣或非侵襲性呼吸器之病患。病患住院3天內,且入住ICU 24小時內或未入住ICU但發炎指數上升(CRP>=7.5 mg/dL) 。劑量：8mg/kg,單次靜脈注射,至多800mg [Micromedex 20210623] COVID-19 (Severe) - Pneumonia 8 mg/kg (actual body weight) as single IV dose, Maximum dose 800 mg; give in combination with dexamethasone 6 mg IV or orally daily for up to 10 days or another corticosteroid at an equivalent dose (guideline dosage)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | Actemra is contraindicated in patients with a known hypersensitivity to tocilizumab or to any of the excipients.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Adverse Effects    | Common Cardiovascular: Hypertension (Adult, 4% to 6% ) Dermatologic: Injection site reaction ( Rheumatoid arthritis, 2.4% to 10.1% ; polyarticular juvenile idiopathic arthritis, 28.8% ; systemic juvenile idiopathic arthritis, 41.2% ), Rash (Rheumatoid arthritis, 2% to 4% ) Gastrointestinal: Diarrhea (Pediatric, greater than 5% ), Upper abdominal pain (Adult, 2% to 3% ) Hepatic: ALT/SGPT level raised (Rheumatoid arthritis, 0.7% to 48%; polyarticular or systemic juvenile idiopathic arthritis, 4% to 13% ), Aspartate aminotransferase serum level raised (Rheumatoid arthritis, 0.1% to 41%; polyarticular or systemic juvenile idiopathic arthritis, less than 1% to 5% ) Neurologic: Dizziness (Adult, 2% to 3% ), Headache (Adults, 5% to 7%; pediatric, greater than 5% ) Respiratory: Nasopharyngitis (Rheumatoid arthritis, 4% to 7%; systemic juvenile idiopathic arthritis, 5% or higher ) Other: Infusion reaction (Rheumatoid arthritis, 7% to 8%; polyarticular juvenile idiopathic arthritis, 16% to 20.2% ) Serious Gastrointestinal: Gastrointestinal perforation, Pancreatitis Hematologic: Decreased platelet count (1% to 4% ), Neutropenia (Rheumatoid arthritis, 1.8% to 3.7% ; polyarticular or systemic juvenile idiopathic arthritis, 7% to 15.4% ) Hepatic: Hepatotoxicity Immunologic: Anaphylaxis, Hypersensitivity reaction (Up to 0.9% ), Opportunistic infection, Tuberculosis Respiratory: Upper respiratory infection (Rheumatoid arthritis, 6% to 8%; systemic juvenile idiopathic arthritis, 5% or higher ) Other: Cancer, Severe infectious disease |
| Pregnancy          | No (Limited) Human Data – Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| More Info          | [UpToDate](https://www.uptodate.com/contents/tocilizumab-drug-information){:target="_blank"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

## Actemra Infusion 200mg/10mL/Vial 專案(限Covid-19)

##### 臨採

| TAH Drug Code      | [IACTMV10](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IACTMV10){:target="_blank"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Rheumatoid Arthritis (RA); Polyarticular Juvenile Idiopathic Arthritis (pJIA); Systemic Juvenile Idiopathic Arthritis (sJIA).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | TFDA新型冠狀病毒（SARS-CoV-2）感染臨床處置暫行指引第十一版: 與dexamethasone合併用於嚴重肺炎以上(未使用吸氧治療下SpO2=<94%、需使用吸氧治療、高流量氧氣或非侵襲性呼吸器、使用機械式呼吸器或ECMO)之病患；或與dexamethasone + remdesivir 合併用於未使用吸氧治療下SpO2=<94%、需使用吸氧治療、高流量氧氣或非侵襲性呼吸器之病患。病患住院3天內,且入住ICU 24小時內或未入住ICU但發炎指數上升(CRP>=7.5 mg/dL) 。劑量：8mg/kg,單次靜脈注射,至多800mg [Micromedex 20210623] COVID-19 (Severe) - Pneumonia 8 mg/kg (actual body weight) as single IV dose, Maximum dose 800 mg; give in combination with dexamethasone 6 mg IV or orally daily for up to 10 days or another corticosteroid at an equivalent dose (guideline dosage)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | Actemra is contraindicated in patients with a known hypersensitivity to tocilizumab or to any of the excipients.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Adverse Effects    | Common Cardiovascular: Hypertension (Adult, 4% to 6% ) Dermatologic: Injection site reaction ( Rheumatoid arthritis, 2.4% to 10.1% ; polyarticular juvenile idiopathic arthritis, 28.8% ; systemic juvenile idiopathic arthritis, 41.2% ), Rash (Rheumatoid arthritis, 2% to 4% ) Gastrointestinal: Diarrhea (Pediatric, greater than 5% ), Upper abdominal pain (Adult, 2% to 3% ) Hepatic: ALT/SGPT level raised (Rheumatoid arthritis, 0.7% to 48%; polyarticular or systemic juvenile idiopathic arthritis, 4% to 13% ), Aspartate aminotransferase serum level raised (Rheumatoid arthritis, 0.1% to 41%; polyarticular or systemic juvenile idiopathic arthritis, less than 1% to 5% ) Neurologic: Dizziness (Adult, 2% to 3% ), Headache (Adults, 5% to 7%; pediatric, greater than 5% ) Respiratory: Nasopharyngitis (Rheumatoid arthritis, 4% to 7%; systemic juvenile idiopathic arthritis, 5% or higher ) Other: Infusion reaction (Rheumatoid arthritis, 7% to 8%; polyarticular juvenile idiopathic arthritis, 16% to 20.2% ) Serious Gastrointestinal: Gastrointestinal perforation, Pancreatitis Hematologic: Decreased platelet count (1% to 4% ), Neutropenia (Rheumatoid arthritis, 1.8% to 3.7% ; polyarticular or systemic juvenile idiopathic arthritis, 7% to 15.4% ) Hepatic: Hepatotoxicity Immunologic: Anaphylaxis, Hypersensitivity reaction (Up to 0.9% ), Opportunistic infection, Tuberculosis Respiratory: Upper respiratory infection (Rheumatoid arthritis, 6% to 8%; systemic juvenile idiopathic arthritis, 5% or higher ) Other: Cancer, Severe infectious disease |
| Pregnancy          | No (Limited) Human Data – Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| More Info          | [UpToDate](https://www.uptodate.com/contents/tocilizumab-drug-information){:target="_blank"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

